Updates on the Electrocardiogram in Acute Coronary Syndromes
- 2.8k Downloads
The electrocardiogram (ECG) is the initial test in patients with suspected ACS. The ECG is the defining element of ST-segment elevation myocardial infarction (STEMI). Its most important use is in the detection of acute coronary obstruction, and it is the most important, cost-effective, and immediately available initial test in the decision for emergency reperfusion therapy. There is a recent interest in refining the sensitivity and specificity of the ECG for coronary occlusion, and thus for identifying subtle STEMI, as well as in recognizing pseudoinfarction patterns and thus avoiding false positive cath lab activations. Studies assessing the accuracy of cath lab activation, the differentiation of precordial ST-segment elevation due to normal variant from that of anterior STEMI, the diagnosis of STEMI in the presence of left bundle branch block, the differentiation of benign inferior ST-segment elevation from that of inferior STEMI, and the importance of ST-segment elevation in lead aVR will be discussed.
KeywordsElectrocardiogram ST-segment elevation myocardial infarction (STEMI) Coronary occlusion Acute coronary syndromes STEMI-equivalent Catherization laboratory activation
The Electrocardiogram in Acute Coronary Syndromes: Recent Articles
The electrocardiogram (ECG) continues to be the initial clinical test in patients with suspected acute coronary syndromes (ACS). Recently there has been an increased focus on the accuracy of the ECG interpretation, on the misinterpretation rate, and on false positive and false negative cath lab activation rates. There has also been some effort to find specific ECG features that may help to distinguish true ACS ECGs from non-ACS ECGs that mimic ACS. We will cover some of the most important below.
Pseudoinfarction, Missed STEMI, and Appropriate Cath Lab Activation
Every physician who treats patients with chest pain knows that the differential diagnosis of ST-segment elevation (STE) includes more than just ST-segment elevation myocardial infarction (STEMI), and knows also that the ECG diagnosis is not always easy. The “pseudoinfarction” patterns include, but are not limited to, early repolarization, left ventricular aneurysm morphology, pericarditis, left ventricular hypertrophy (LVH), WPW, Brugada and, of course, left bundle branch block (LBBB).
To demonstrate this, Jayroe et al.  distributed difficult ECGs to 15 “expert” electrocardiographers (all cardiologists), with a clinical scenario suggestive of ischemia. There were 108 nonischemic ECGs with STE of various causes and eight STEMIs; mean sensitivity and specificity of the readers were 75 % and 85 %, respectively. This was similar to Turnipseed’s 2005 study  in which neither emergency physicians nor cardiologists performed well in differentiating early repolarization from STEMI. More recently, Tran et al.  studied the ECGs and records of 240 consecutive catheterization laboratory activations for STEMI. They excluded patients with LBBB or paced rhythms and others whose STE criteria did not meet guideline-based criteria for acute STEMI. They did detailed chart reviews to determine if there was or was not actually a STEMI, in retrospect, by examining cath results, echocardiograms, biomarkers, etc. They then showed these ECGs to seven experienced interventional cardiologists and asked them to interpret the ECGs, blinded the outcome, and asked whether they would recommend immediate percutaneous coronary intervention (PCI), assuming that the patient had appropriate ischemic symptoms. Of 84 subjects, there were 40 patients with a true STEMI and 44 without (13 of whom had non-STEMI). Recommendations for immediate PCI varied widely, from 33 to 75 %. Sensitivities were 53–83 % (mean, 71 %), specificities 32–86 % (mean 63 %); PPV ranged from 52 to 79 % (mean 66 %) and NPV ranged from 67 to 79 % (mean 71 %). When the readers chose non-ischemic ST elevation, LVH was thought to be the cause in 6–31 % and old MI/LV aneurysm in 10–26 %. Thus, even among the “experts”, STE is very difficult to interpret.
Past studies show that only 67–80 % of STEMI patients whose ECGs make them clearly eligible for reperfusion therapy receive it [4, 5, 6]. In 2008, Tricomi et al.  found that only 78 % of patients clearly eligible for reperfusion therapy received it. One third of those had unrecognized STE.
However, there are many coronary occlusions which do not, even in retrospect, get classified as STEMIs. Wang et al. recently showed that in 28 % of non-STEMIs, the infarct-related artery (IRA) is occluded, and that in these patients biomarker levels and mortality are higher than in non-STEMIs without an occluded IRA. However, there is no in-depth ECG analysis to discover ECG findings helpful in identifying this group [8•]. From et al.  similarly showed that one fourth of non-STEMIs have an occluded IRA, and that 20 % of these were right coronary, 17 % left anterior descending (LAD), and 30 % were circumflex artery occlusions. These would be “STEMI-equivalents” (the term for ACS which has occlusion or near occlusion, but in the absence of classic ST elevation; there is potential for imminent irreversible loss of myocardium, and emergent angiography and PCI may be indicated) . I have personally seen ECGs of many patients who had a coronary occlusion that was not recognized, but whose subtle ECG findings were diagnostic or highly suggestive, such that further immediate investigation with echocardiography or angiography would be warranted. As in the study of Wang et al., these patients later ruled-in for acute myocardial infarction (AMI) by very high biomarkers, got a non-urgent angiogram and were diagnosed with non-STEMI in spite of coronary occlusion and subtle STE. Even the aforementioned studies underestimate the number of missed occlusions, as it is well known that by the time of a delayed angiogram in patients with known, diagnosed STEMI, 20–25 % of occluded arteries have recanalized (spontaneously reperfused without therapy or due to therapy for non-STEMI) [11, 12]. These patients often have very high biomarker levels and a significant wall motion abnormality. Unfortunately, few studies other than those mentioned have looked at the rate of failure to diagnose coronary occlusion (false negative cath lab activation rate). One study asserted that “there were no cases in which STEMI was not recognized by the emergency physician during the study period;” however, they only reviewed cath lab activation cases and so could only possibly find false positives, not false negatives . Thus, we are only beginning to discover the true incidence of missed STEMI-equivalents, and are at an even more rudimentary stage of identifying them on the ECG.
Conversely, there is a body of literature which assesses false positive activations. A study from 2007 showed an approximate 10 % rate of normal coronaries in patients who are referred for immediate PCI for STEMI; in this study, false positives were underestimated because patients with non-STEMI, and sometimes those with simple stable coronary disease, were not considered false positives . In a study by Kontos et al. , false positives were assessed by use of millimeter criteria, which may be very nonspecific . Garvey et al.  studied 3,973 cath lab activations at 14 PCI hospitals, and used the interventionalists’ opinions (cancellation of cath lab activation) as the outcome measure for whether cath lab activation was “appropriate.” But it is clear from Tran et. al. (discussed above)  that interventionalists’ opinions are not an appropriate reference standard. Two other studies found 7.2 and 17 % of STEMI cath lab activations were false alarms [17, 18]. However, their endpoints for “false positive” were defined by “no culprit lesion found,” an inappropriate endpoint: non-STEMIs also have culprit lesions and to routinely activate the cath lab emergently in these cases is usually an inappropriate use of resources.
Finally, only one study I am aware of has addressed the problem of false positive activations appropriately . In this study, a true positive required a flow grade less than thrombolysis in myocardial infarction (TIMI) grade 3 flow in at least one artery, and found that 36 % of cases were false positive activations. This study was criticized by editorialists for using a retrospective methodology . It is indeed inappropriate to use retrospective analysis to criticize those who activate the cath lab, but it is only through analysis of cases that do not have TIMI-3 flow, vs. those that do, that we can improve ECG criteria for activation. Unfortunately, this study did not do ECG analysis.
Thus, studies looking at false positive rates use as outcome measures: (1) an “expert” interpretation  or; (2) the presence of a positive biomarker (troponin) at any level and an angiographic culprit lesion, whether occluded or not  or; (3) STE criteria . In a different study by Kontos et al. , of LBBB, there was an assessment of biomarker level (CK-MB) at 5 × the upper limit of normal. In our retrospective study of LBBB [22••, 23, 24, 25] we required documented occlusion or a culprit lesion with a peak troponin I of at least 10 ng/ml, as most true STEMI have at least this level, and most true non-STEMI do not [26, 27, 28, 29]. Until all ECG in ACS studies consistently assess ECG features of ischemia during proven occlusion, and contrast them to those who are proven not to have occlusion, we will make little progress on improving ECG recognition of this coronary event. Thus, in order to better elucidate which ECG findings are indicative of occlusion, we need more angiographically-based ECG research.
In any case, there has been a recent effort to expand on the ECG indications for immediate reperfusion, and these include such purported STEMI-equivalents as new, or presumed new, LBBB, pre-existing LBBB with Sgarbossa concordance, isolated posterior MI, ST elevation in aVR because of its association with left main ACS, de Winter’s ST/T-waves, and hyperacute T-waves . We will cover some of these in the following paragraphs.
Differentiation of Anterior Normal Variant ST Elevation from Anterior STEMI
Diagnostic utility of various STEMI voltage criteria in subtle MI vs. ER, both derivation and validation groups combined (n = 314; 143 STEMI, 171 ER)
At least two consecutive leads with STE:
Location of STE measurement
LR+ (95 % CI)
LR− (95 % CI)
1) ≥1 mm V1–V6
1.0 (0.7, 1.5)
0.9 (0.5, 1.4)
1.0 (0.9, 1.0)
5.0 (0.6, 45)
2) ≥2 mm in any of V1–V3 or >1 mm V4–V6 
1.4 (1.1, 1.6)
0.7 (0.5, 0.9)
1.2 (0.9, 1.5)
0.6 (0.4, 0.9)
3) ≥1 mm V1, V4–V6 or ≥2 mmV2–V3
1.3 (1.0, 1.5)
0.7 (0.6, 0.9)
1.2 (0.9, 1.5)
0.5 (0.3, 0.8)
4) ≥1 mm V1, V4–V6 or >2 mm V2–V3 (men) or >1.5 mm in V2–V3 (women)
1.3 (1.0, 1.6)
0.7 (0.5, 0.9)
1.1. (0.8, 1.5)
0.5 (0.3, 0.8)
5) ≥1 mm in V1, V4–V6, or ≥2 mm V2–V3 (men) or ≥2.5 mm in V2–V3 (men < 40 years old) or ≥1.5 mm in V2–V3 (women) 
1.5 (1.2, 1.7)
0.6 (0.3, 0.8)
1.2 (0.9, 1.6)
0.3 (0.2, 0.6)
6) ≥1 mm, V5–V6 or ≥2 mm V1–V4
1.7 (1.4, 2.0)
0.7 (0.5, 0.9)
1.3 (1.0, 1.6)
0.5 (0.4, 0.8)
ECG criterion: STEMI if > 23.4: (1.196 × STE60 V3) + (0.059 × QTc) − (0.326 × RA V4)
9.2 (8.5, 10)
0.1 (0.08, 0.3)
A “New” Sign of LAD Pcclusion (“de Winters” T-Waves)
Differentiation of Normal Variant Inferior ST Elevation and that of Pericarditis from that of Inferior Wall STEMI: Lead aVL
Inferior STE may be due to a variety of conditions, and it may be difficult to accurately diagnose subtle inferior STEMI. In order to better understand this, we studied 156 patients with inferior STEMI and compared them to 39 ED chest pain patients with a discharge diagnosis of pericarditis (all ruled out for AMI) with inferior ST elevation and to 66 patients with baseline inferior ST elevation (limb lead early repolarization pattern). All but one inferior STEMI ECG had some amount of reciprocal ST depression in lead aVL, whereas none of the 105 controls had this finding. The initial ECG did not meet reperfusion “criteria” of 1 mm STE in two consecutive leads in 28 % of cases, but in all of these there was some ST depression in aVL. Overall diagnostic performance of STD in aVL for STEMI vs. no-AMI were sensitivity 99 % (95 % CI: 96–100 %) and specificity 100 % (95 % CI: 95.6–100 %) . We also found that, in pericarditis, ST elevation in lead II was always higher than in lead III. This is consistent with two studies by Spodick, in which all cases of pericarditis had an ST axis between 0 and 90 (STE in lead II > STE in lead III) [38, 39]. However, others recently found the exact opposite: only 19 of 122 “pericarditis” cases had ST elevation in lead II > III; this study is difficult to evaluate . Finally, it is possible to have STE in lead II > STE lead III simultaneous with ST depression in aVL if the ST axis is between 60° and 90°, and approximately 10 % of our cases fit this category. I have personally never seen a case of even inferolateral STEMI that did not have at least a hint of ST depression in lead aVL, but it is theoretically possible that STEMI with lateral ST elevation (leads V5, V6) may have a falsely isoelectric or elevated ST segment in lead aVL, and to assess these with great caution. I believe this is one of the most difficult of all infarction/pseudoinfarction differential diagnoses. The inferolateral ECG leads are the most commonly involved ones in pericarditis (personal data), and these walls are also the most commonly involved by MRI analysis .
That there is no reciprocal STD in pericarditis conforms with previous thinking on these ST elevation variants, except that it is thought that patients with localized pericarditis may present with reciprocal ST depression if, for instance, the inflamed area of the heart is the inferior wall. The assertion has been made that regional ECG changes associated with pericarditis are due to postinfarction pericarditis . However, we are not aware of data on this. Of 45 cases of apparent MI but with normal angiograms, 37 had myocarditis by Indium scintigraphy; although 23 had regional wall motion abnormalities, only two of these had any ST depression on the ECG .
It is important to understand that there are other etiologies of inferior ST-elevation with reciprocal ST depression in aVL that may be confused with inferior STEMI; these included Wolff–Parkinson–White syndrome, LVH of the limb leads, inferior left ventricular aneurysm morphology (persistent ST elevation after previous inferior MI), LBBB, and paced rhythm.
Left Bundle Branch Block and AMI
The ACC/AHA recommends reperfusion therapy for patients with ischemic symptoms and new LBBB, while also applying the Sgarbossa criteria . The 2007 and 2009 focused updates do not further comment on this issue [45, 46]. It is becoming increasingly clear that most such patients do not have AMI and especially do not have acute coronary occlusion. Past ED studies show that the incidence of AMI in ED chest pain patients, as diagnosed by CK-MB, is low, at about 13 % [47, 48]. More recently, Chang et al.  found the incidence of troponin-diagnosed AMI in patients with LBBB at 5.2 % and with new LBBB at 7.3 %. As approximately 30 % of troponin-diagnosed AMI patients have STEMI , it is probable that only about 2–4 % of patients with chest pain and LBBB have STEMI.
On the other hand, Kontos et al.  recently published data on 401 patients with LBBB undergoing a “rule-out AMI protocol.” Of these, 64 % had new (37 %) or presumably new (27 %) LBBB; 116 (29 %) of patients had AMI. Of those with at least 1 mm of concordant ST-segment deviation, 86 % had AMI, and peak CK-MB at least 5 × normal (used as a STEMI-equivalent surrogate) occurred in 50 % of them vs. none of those who did not. A concordant ST segment was an important predictor of AMI (odds ratio 17). This study combined the data from Kontos’ previous study , in which only 24 of 182 (13 %) consecutive patients had AMI, was included. The latter half of the study, with 219 patients and 82 (37 %) AMI, had a much higher incidence of AMI because this group consisted only of admitted patients (personal communication, Michael C. Kontos, Virginia Commonwealth University, August 2012).
More recent studies confirm the low incidence of AMI and STEMI in these patients. Joshil et al.  reported on 177 LBBB patients referred for primary PCI (pPCI). Of these, 47 (26.5 %) had AMI, but only 9 (5 %) had > 70 % stenosis, only 6 (3.4 %) had pPCI, and only one had 100 % occlusion. Jain et al. reported that, of 35 LBBB patients with suspected ACS referred to The Mayo Clinic over 5 years for pPCI, only 14 had ACS (12 AMI), and only five had occluded culprit arteries .
Finally, after adjustment for multiple differences, patients with LBBB who undergo reperfusion therapy for suspected AMI have a better prognosis than STEMI patients with normal conduction (OR for in-hospital mortality, 0.610, CI 0.571–0.655) because they do not, unlike the STEMI patients, actually have occlusion .
In spite of the fact that LBBB patients who do actually have AMI have a worse prognosis than those with normal conduction, clinicians have never consistently followed the ACC/AHA guidelines . Therefore, it is critical to find an accurate means of diagnosing STEMI in the presence of LBBB on the ECG. Unfortunately, the Sgarbossa criteria have not succeeded, partly because the third criterion is not sensitive and specific enough , and partly because it has not been widely evaluated using angiography as an endpoint; instead the usual endpoint has been AMI as diagnosed by CK-MB, and this definition includes non-STEMI. ECGs with normal conduction have only 45 % sensitivity for all AMI, but good sensitivity for STEMI [56, 57, 58, 59].
We found in a retrospective study of 33 patients with LBBB and occlusion, compared to 129 without occlusion (including 24 with biomarker diagnosed AMI), that a refinement of the Sgarbossa rule which replaces the third component (excessively discordant STE as defined by ≥5 mm) with a proportional definition (absolute value of ST/S ratio ≥ 0.25), was more sensitive (91 %) than either the weighted Sgarbossa rule (52 %) or the unweighted rule (67 %). The specificity (90 %) was lower than the original rule (98 %) but the same as the unweighted rule. It was more accurate than either, both of which use a 5 mm absolute number [22••, 23, 24, 25, 60, 61]. Because we used a very strict angiographic occlusion endpoint rather than biomarker-diagnose AMI, the sensitivity of both rules was far higher than in previous studies, but conforms with studies of angiographic balloon occlusion . We believe that the ECG is indeed sensitive and specific for complete occlusion, and that it remains the central test in determining need for emergency reperfusion, even in patients with LBBB.
Importantly, we found that another rule, any excessively discordant ST elevation or ST depression (as defined by the absolute value of the ST/S ratio or ST/R ratio ≥ 0.30), was the most sensitive and specific of all. However, as this does not use ST elevation, it may not be widely accepted. Optimally, there would be validation studies of both rules and of the optimal cutpoints of ≥0.25 and ≥0.30.
Lead aVR in Acute Coronary Syndromes
There is a body of literature in the past decade on the significance of STE in lead aVR in ACS, and especially for its significance for diagnosis of left main coronary artery (LMCA) obstruction and three-vessel disease [63, 64, 65, 66, 67, 68]. The literature is confusing for a few reasons. First, studies do not always clearly distinguish patients with and without STEMI. Second, LMCA “obstruction” is rarely defined, leaving it ambiguous as to whether the obstruction is (1) complete, (2) incomplete (subtotal), (3) complete but with good collateral circulation or (4) intermittent. Third, the studies were nearly all small with a retrospectively identified group with LMCA ACS. Fourth, findings may be influence by individual anatomy, ischemic preconditioning, and the timing of ECG recording. Since patients with LMCA occlusion do not often survive to the cath lab, the pretest probability for any positive ECG findings is low, and any reported sensitivities and specificities may distort the clinician’s assessment of the actual presence of disease.
Lead aVR in STEMI
Lead aVR in STEMI is touted as important for recognizing LMCA occlusion . Since patients with STEMI are already identified as a group which needs immediate reperfusion therapy, the primary importance of recognizing LMCA involvement in STEMI is (1) to recognize the increased mortality associated with this finding and (2) in the potential to avoid thienopyridine (e.g., clopidogrel) administration in such patients who are likely to need CABG and may suffer from excessive bleeding if they do receive a thienopyridine.
Only 0.19–1.3 % of STEMI patients have LMCA occlusion, or 0.42–3 % of anterior STEMI [69, 70], partly because patients with occlusion (or obstruction) do not frequently survive to the cath lab. Mortality is 50 %, and over 70 % present in cardiogenic shock, such that the diagnosis of severe ACS and need for cath lab activation is usually apparent from the clinical presentation, rather than the ECG. In contrast, approximately 10 % of patients with anterior STEMI have STE of at least 1 mm in aVR (as measured at 60 ms after the J-point) , and 25 % have at least 0.5 mm STE in aVR (as measured at 60 ms after the J-point, relative to the TP segment) . STE or STD of 1 mm or more in anterior STEMI portended a worse prognosis (compared to no STE or STD), even after correcting for STE or STD elsewhere on the ECG, but only ST depression in aVR (“reciprocal to injury in the area of lead V7”) remained significant when corrected for all other ECG and clinical factors . STE in aVR of at least 0.5 mm in anterior STEMI predicts septal AMI (occlusion of the LAD proximal to the first septal perforator) with a PPV and NPV of 70 % and 80 % better than STE in V1, which at a cutoff of >2.5 mm had 12 % sensitivity and 100 % specificity, with PPV and NPV of 100 and 39 % . Kotoku et al.  similarly found that STE in aVR correlated with proximal (vs. distal) LAD occlusion and was negatively correlated with a long (vs. short), or wraparound, LAD that affected the inferior wall. This is intuitive, as a proximal occlusion would lead to basal wall STEMI (see below), and distal occlusion of a wraparound (long, “type III”) LAD would lead to inferior STE which would reciprocally attenuate the STE in aVR, or lead to STD in aVR. To be complete, Wong also found that STE in aVR in inferior STEMI conferred worse outcomes .
The study by Yamaji et al.  is cited as evidence that STE in aVR > STE in V1 is 81 % sensitive and 80 % specific for identifying the LMCA as the culprit [incidentally, this study has been cited among the general ACS literature;  however, it applies to STEMI only, as methods required TIMI 0–1 flow]. If its conclusions are accurate, and one considers that 0.4–3 % of LMCA occlusions make it to the cath lab alive, then the positive predictive value (PPV) of STE in aVR > STE in V1 is only 1.6–11 %, rendering this finding useless. Furthermore, in the study by Kurisu et al.  of consecutive STEMI, written as a letter, 25 (about 3 % of those with anterior STE) had LMCA occlusion; they compared ECG measurements of the 25 LMCA occlusions to only 30 each of consecutive LAD, RCA, and circumflex occlusions and found sensitivity and specificity for LMCA, vs. LAD, of STE in aVR > STE in V1 of 40 % and 93 %, resulting in a PPV of only 15 %.
A suggested explanation for STE in aVR > V1 in LMCA STEMI (due to occlusion) is that aVR overlies the injured basal septum. The STE registered in V1, and presumably also other right precordial leads V2–V4, is partly attenuated by the reciprocal ST depression of the posterior wall STEMI that is due to obstruction of flow in the circumflex artery. The most likely explanation for STE in both aVL and aVR is similar: in addition to anterior and basal septal STEMI, there is high lateral STEMI from absence of circumflex, such that the ST vector is superior (a “superior” STEMI), as well as anterior .
Lead aVR in Non-STE-ACS
Lead aVR has been ignored in the past because it is 180° opposite from an imaginary lead between leads I and II, and therefore would provide no independent data. More recent claims that ST elevation in aVR is independent of ST depression in these opposing leads have not been substantiated for non-STEMI, though this appears to be true for STEMI (see above). Nevertheless, it is convenient to use one lead with ST elevation (aVR) as a substitute for many others with ST depression, such that, in non-STE-ACS, the degree of ST elevation in aVR correlates with the number of leads with ST depression, the depth of the ST depression, and the sum of ST depressions [67, 73, 74, 75, 76]. In all studies, measurements of the ST segment are at 80 ms after the J-point for ST depression and 20 ms after the J-point for ST elevation, both relative to the TP segment.
To very briefly summarize the literature, diffuse ST depression has a good PPV and NPV for three-vessel and left main disease [73, 77]. The degree of STE in aVR, though not independent of ST depression, has strong association with outcome independent of clinical factors such as Killip class and blood pressure [74, 76]. Barrabes et al.  studied 775 non-STEMIs and found that, compared to no STE in aVR, STE of 0.5 to 1.0 mm had odds ratio (OR) for death of 4.2 (1.5–12.2), and STE of ≥1.0 mm had OR of 6.6 (2.5–17.6). There were 475 who underwent angiography; of those with ≥1 mm of STE in aVR (n = 92), 48 % had three-vessel disease and 18 % had LMCA disease, compared to 21 and 4 % for those with <1 mm STE in aVR . Kosuge et al.  studied 310 patients with ACS without STE. They found that STE in aVR of ≥0.5 mm was the strongest predictor of LMCA or three-vessel disease, with an OR of 19.7, and it identified LMCA or three-vessel disease with 78 % sensitivity and 86 % specificity, and a PPV and NPV of 57 and 95 %. Finally, Szymanski et al. in 2008 found mortality correlated with the degree of STE in lead aVR, independent of TIMI score, and was highly associated with ST depression in multiple locations.
In 2011, Kosuge et al.  studied 572 patients with non-STE-ACS; among the 196 with a positive troponin T on admission, the sensitivity and specificity of STE ≥ 1.0 mm in aVR for LMCA or three-vessel disease was 80 and 93 %, with a PPV of 56 % and an NPV of 98 %, and accuracy of 92 %. OR of degree of STE in aVR for severe three-vessel or LMCA disease among all patients was 29 (9.5–50). CABG was undertaken in 46 % of those with severe 3-vessel or LMCA disease vs. 2 % of those without. The authors suggest withholding clopidogrel in patients with non-STEMI and STE in aVR of at least 1 mm.
Summary of Lead aVR in ACS
Thus, STE in aVR in non-STEMI, though not independent of ST depression elsewhere, is a good approximation of the sum of STD and is a very useful predictor of poor outcomes and of need for CABG, independent of other clinical data. STE in aVR is generally reciprocal to diffuse ST depression, opposite to a negative ST vector towards I, II, and V5, and is a result of subendocardial ischemia. On the other hand, the STE in aVR in STEMI, usually anterior STEMI, is more likely a result of transmural injury (STEMI of the basal septum). In this latter case the STE in aVR is not reciprocal to any ST depression, but directly indicative of injury.
In non-STEMI, if there is STE in aVR ≥ 1.0 mm, it may be prudent to withhold clopidogrel
In both STEMI and non-STEMI, the degree of STE in aVR correlates with worse disease and worse outcomes, independent of the clinical presentation; these patients must be treated aggressively with early angiography and revascularization.
It remains a challenge to appropriately apply reperfusion therapy to patients with ischemia symptoms. Although the ECG is the first critical test, its accuracy as applied today is not optimal. There have recently been a few studies using angiographic outcomes to attempt to find features of the ECG which correlate highly with coronary obstruction and can help to detect electrocardiographically subtle STEMI and differentiate it from the look-alikes. The key ones are described here. I hope for more such research in the future.
No potential conflicts of interest relevant to this article were reported.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 8.• Wang T, Zhang M, Fu Y, et al. Incidence, distribution, and prognostic impact of occluded culprit arteries among patients with non–ST-elevation acute coronary syndromes undergoing diagnostic angiography Am Heart J. 2009;157(4):716–23.Google Scholar
These articles demonstrates that a high proportion of “Non-STEMIs” have an occluded infarct-related artery, and that these patients have worse outcomes. This demonstrates that the standard definition of STEMI, which is dependent upon criterion-based ECG findings such as millimeters of ST elevation, is insufficient to identify patients with ACS who have occlusion, and that more work needs to be done to identify such patients, whether using the ECG or other modalities.
- 15.Smith SW, Khalil A, Henry TD, et al. Electrocardiographic differentiation of early repolarization from subtle anterior ST-segment elevation myocardial infarction. Ann Emerg Med. 2012;60(1):45–56.Google Scholar
- 16.Garvey JL, Monk L, Granger CB, et al. Rates of cardiac catheterization cancelation for ST-segment elevation myocardial infarction after activation by emergency medical services or emergency physicians: results from the North Carolina catheterization laboratory activation registry. Circulation. 2012;125(2):308–13.PubMedCrossRefGoogle Scholar
- 17.Sawyer KN, Robinson AL, Roberts CS, Kurz MC, Kontos MC. Prevalence and ECG findings for patients with false-positive cardiac catheterization laboratory activation among patients with suspected ST-segment elevation myocardial infarction (Abstract 189). Acad Emerg Med. 2012;19(s1):S102–3.Google Scholar
- 19.McCabe JM, Armstrong EJ, Kulkarni A, et al. Prevalence and factors associated with false-positive ST-segment elevation myocardial infarction diagnoses at primary percutaneous coronary intervention-capable centers: a report from the activate-SF registry. Arch Intern Med. 2012;172:864–71.PubMedCrossRefGoogle Scholar
- 20.Bachour F, Asinger R. Activating primary percutaneous coronary intervention for STEMI that is not: comment on “prevalence and factors associated with false-positive ST-Segment elevation myocardial infarction diagnoses at primary percutaneous coronary intervention-capable centers”. Arch Intern Med. 2012; 871–2.Google Scholar
- 22.•• Smith SW, Dodd KW, Henry TD, Dvorak DM, Pearce LA. Diagnosis of ST elevation myocardial infarction in the presence of left bundle branch block using the ST elevation to S-wave ratio in a modified Sgarbossa rule. Ann Emerg Med. 2012;60(6):766–76.Google Scholar
This article demonstrates that millimeter criteria of ST-segment elevation are very poor at differentiating anterior STEMI from early repolarization, that the R-wave amplitude is more important than ST elevation, and that by using three variables, ST elevation, R-wave amplitude, and corrected QT interval, one can differentiate the two entities with a high degree of accuracy
- 24.Dodd KW, Aramburo L, Henry TD, Smith SW. Ratio of discordant ST segment elevation or depression to QRS complex amplitude is an accurate diagnostic criterion of acute myocardial infarction in the presence of left bundle branch block (Abstract 551). Circulation. 2008;118(18 Supplement):S_578.Google Scholar
- 25.Dodd KW, Aramburo L, Broberg E, Smith SW. For diagnosis of acute anterior myocardial infarction due to left anterior descending artery occlusion in left bundle branch block, High ST/S Ratio is more accurate than convex ST segment morphology (Abstract 583). Acad Emerg Med. 2010;17(S1):S196.Google Scholar
- 28.Chia S, Senatore F, Raffel OC, Lee H, Wackers FJ, Jang IK. Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Jacc. 2008;1(4):415–23.PubMedGoogle Scholar
- 32.Wagner GS, Macfarlane P, Wellens H, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part VI: acute ischemia/infarction: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol. 2009;53(11):1003–11.PubMedCrossRefGoogle Scholar
- 33.• Verouden NJ, Koch KT, Peters RJ, et al. Persistent precordial ‘hyper acute’ T-waves signify proximal LAD artery occlusion. Heart 2009;95:1701–6.Google Scholar
This paper describes fully, for the first time, an uncommon but important ECG manifestation of LAD occlusion: ST depression followed by a large T-wave
- 34.Marriott HJL. Practical electrocardiography. 7th ed. Baltimore: Williams and Wilkins; 1983.Google Scholar
- 35.Smith SW, Zvosec DL, Henry TD, Sharkey SW, editors. The ECG in acute MI: an evidence-based manual of reperfusion therapy. 1st ed. Philadelphia: Lippincott, Williams and Wilkins; 2002.Google Scholar
- 36.Soo CS. Tall precordial T waves with depressed ST take-off: an early sign of acute myocardial infarction. Singapore Med J. 1995;36(2):236–7.Google Scholar
- 37.Bischof J, Thompson RP, Tikkanen JT, et al. ST Depression in AVL differentiates inferior ST elevation myocardial infarction from benign causes of inferior ST elevation (Abstract 21). Ann Emerg Med. 2012;60(4 Suppl):S8–9.Google Scholar
- 38.Spodick DH. The electrocardiogram in acute pericarditis: distributions of morphologic and axial changes in stages. Prog Cardiovasc Dis. 1974;33:470–4.Google Scholar
- 40.Henning DJ, Fjaeldstad AE, Moeller CM, Fogel M, Fischer CM, Ullman EA. Evaluating a rule for differentiating pericardial disease from ST-segment elevation myocardial infarction. Acad Emerg Med. 2011;18(1 Suppl):S16.Google Scholar
- 44.Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction–executive summary. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol. 2004;44(3):671–719.PubMedCrossRefGoogle Scholar
- 45.Kushner FG, Hand M, Smith SC Jr, et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2009;54(23):2205–41.PubMedCrossRefGoogle Scholar
- 53.Poon K, Frederick PD, French WJ. Does a new or presumed new left bundle branch block have equivalent mortality to an acute ST-elevation myocardial infarction? (Abstract 4317). Circulation 2009;120(18_Suppl_2):S935.Google Scholar
- 58.Rouan GW, Lee TH, Cook EF, Brand DA, Weisberg MC, Goldman L. Clinical characteristics and outcome of acute myocardial infarction in patients with initially normal or nonspecific electrocardiograms (a report from the multicenter chest pain study). Am J Cardiol. 1989;64(18):1087–92.PubMedCrossRefGoogle Scholar
- 63.Aygul N, Ozdemir K, Tokac M, et al. Value of lead aVR in predicting acute occlusion of proximal left anterior descending coronary artery and in-hospital outcome in ST-elevation myocardial infarction: an electrocardiographic predictor of poor prognosis. J Electrocardiol. 2008;41(4):335–41.PubMedCrossRefGoogle Scholar
- 68.Lead aVR: importance of the “Forgotten 12th Lead” in patients with ACS. medscape emergency medicine. 2009. http://www.medscape.com/viewarticle/589781. Accessed 20 July 2012.
- 69.Zoghbi GJ, Misra VK, Brott BC, et al. ST elevation myocardial infarction due to left main culprit lesions: percutaneous coronary intervention outcomes free. J Am Coll Cardiol. 2010;55(10s1):E1712.Google Scholar
- 77.Barrabes JA, Figueras J, Moure C, Cortadellas J, Soler-Soler J. Prognostic significance of ST segment depression in lateral leads I, aVL, V5 and V6 on the admission electrocardiogram in patients with a first acute myocardial infarction without ST segment elevation. J Am Coll Cardiol. 2000;35(7):1813–9.PubMedCrossRefGoogle Scholar